• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Athersys Inc.

NE Ohio biomedical industry investments on the rise

March 21, 2019 By Nancy Crotti

Investment in the northeast Ohio biomedical sector totaled nearly $294 million in 2018 with 71 regional companies receiving funding, according to regional healthcare trade group BioEnterprise. Those figures make this region the third largest for total healthcare investment in the Midwest, following Minneapolis ($664 million) and Chicago ($551 million). These were among the findings of […]

Filed Under: Biotech, Business/Financial News, Funding Roundup, News Well Tagged With: Athersys Inc., BioEnterprise, ViewRay Inc.

New FDA rules imperil Bioject | Wall Street Beat

April 3, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Bioject (OTC:BJCT) said it’s unsure of its ability to stay afloat after the FDA instituted new rules last year governing jet injection of vaccines, which accounts for about 70% of Bioject’s business, according to a regulatory filing.

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Funding Roundup, News Well, Wall Street Beat Tagged With: Athersys Inc., Avedro Inc., Barclay's, Bioject Medical Technologies Inc., Deals Roundup, EnteroMedics Inc., Hoya Vision, Maquet Cardiovascular LLC, Misonix, Optos Inc., Siemens

Boston Scientific’s Alair asthma treatment gets a thumbs-up | Regulatory Roundup

March 29, 2012 By MassDevice staff Leave a Comment

MassDevice.com Regulatory Roundup

 BSX’s Alair asthma system gets the OK from CTAF

Filed Under: News Well Tagged With: Ablation, Asthma, Athersys Inc., Benvenue Medical Inc, Boston Scientific, California Technology Assessment Forum, dextera, Given Imaging, Imalux Corp., IntelliCell Biosciences, Lucero Medical, Merit Medical Systems, Smiths Medical, SoundCure, SpinalMotion Inc., VentriPoint, Zoll Medical

VCs press Senate on “IPO On Ramp” bill | Wall Street Beat

March 12, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.

The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.

Filed Under: News Well, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Abbott, Allezoe Medical Holdings, Angel Investment, Angel Resource Institute, Athersys Inc., Atrium Medical Corp., Authentidate, avitamedical, Boston Scientific, C.R. Bard, CareFusion Corp., CB Insights, CJPS Healthcare Supplies & Equipment, Dexcom, Edwards Lifesciences, Flextronics, GE Healthcare, Halt Medical, iCad Inc., Intuitive Surgical, Johnson and Johnson, LensAR Inc., Mobi LLC, National Venture Capital Assn., Nihon Kohden, Nobel Biocare Holdings AG, Nuvasive, Philips, Premier Inc., Silicon Valley Bank, Smith & Nephew, Standard & Poor's, Stellar Microelectronics, Thoratec Corp., U.S. Army, U.S. House of Representatives, U.S. Senate, Venture Capital/Private Equity, Volcano Corp., Welch Allyn

iRobot invests $6M into telemedicine company | Funding Roundup

February 2, 2012 By MassDevice staff Leave a Comment

iRobot
InTouch Health

iRobot Corp. (NSDQ: IRBT), famous for their Roomba automated cleaning robots, invested $6 million and launched an extended partnership with InTouch Health, which develops telemedicine systems for providing remote health care.

The venture builds on an existing relationship that the companies announced last summer, under which the companies engaged in a development and licensing agreement.

Filed Under: Funding Roundup, News Well Tagged With: Athersys Inc., CartiHeal Ltd., Checkpoint Surgical, Dana-Farber Cancer Institute, EDAP TMS SA, InterValve Inc., InTouch Health, iRobot, Joslin Diabetes Center, Mevion Medical Systems, nContact Inc., ProUroCare Medical Inc., Remote Patient Monitoring, S.E.A. Medical Systems Inc., SpectraScience Inc., Synchro Medical Solutions, Venture Capital/Private Equity

Covidien beats The Street, confirms 2012 guidance | Earnings Roundup

November 16, 2011 By MassDevice staff Leave a Comment

Covidien

Covidien (NYSE:COV) beat Wall Street’s earnings expectations for both its fourth quarter and 2011 fiscal year, sending shares up 1.8 percent today.

The Mansfield, Mass.-based health care giant’s medical device segment once again led the charge, posting an 18 percent sales increase for Q4 and 17 percent for the full year.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: American Shared Hospital Services, Athersys Inc., BSD Medical Corp., Cambridge Heart Inc., Covidien, Dehaier Medical Systems Ltd., Dynatronics Corp, Guided Therapeutics Inc., HemaCare Corp., InVivo Therapeutics, Q3

Heart attack trials bring good news for Athersys

June 15, 2011 By MedCity News Leave a Comment

Athersys Inc. (NSDQ:ATHX) reported that results from a phase 1 trial of its stem cell therapy suggest its MultiStem technology could hold benefits for heart attack patients.

Filed Under: News Well, Research & Development Tagged With: Athersys Inc., Technologies

Stem cells: Athersys, Pfizer start MultiStem clinical trial for inflammatory bowel disease

March 15, 2011 By MedCity News Leave a Comment

Athersys

Stem cell therapy developer Athersys (NSDQ:ATHX) and partner Pfizer (NYSE:PFE) have begun enrolling patients in a Phase II clinical trial for inflammatory bowel disease.

The trial marks an “important milestone” for Athersys because it’s the first time the company’s MultiStem treatment has advanced to a Phase II trial, CEO Gil Van Bokkelen said in a conference call with analysts to discuss the company’s quarterly financial numbers.

Filed Under: News Well, Stem Cells Tagged With: Athersys Inc., Clinical Trials, Pfizer

Athersys looks to raise $13.1 million in private offering

January 28, 2011 By MedCity News Leave a Comment

ATHX logo

Stem cell company Athersys Inc. (NSDQ:ATHX) has reached an agreement to sell about $13 million of its shares to unidentified private investors.

Athersys will raise the cash by selling about 4.4 million shares of its common stock and warrants to purchase up to an additional 1.3 million shares, according to the company. Adding 5.7 million shares would increase the Cleveland company’s number of shares outstanding by 30 percent to about 25 million.

Filed Under: Business/Financial News, News Well, Stem Cells Tagged With: Athersys Inc.

Athersys touts study findings on stem cell treatment for spinal injury

January 19, 2011 By MedCity News Leave a Comment

ATHX logo

A new study shows Athersys Inc.’s (NSDQ:ATHX) stem cell technology could hold therapeutic benefits in treating spinal cord injuries.

Researchers found that administering Athersys’ MultiStem technology to rodents with spinal injuries reduced inflammation and promoted the regrowth of neurons, according to Athersys and the Case Western Reserve University School of Medicine.

Filed Under: Business/Financial News, News Well, Orthopedics, Stem Cells Tagged With: Athersys Inc.

Athersys wraps up enrollment for first phase of blood cancer study

January 6, 2011 By MedCity News Leave a Comment

ATHX logo

Athersys Inc. (NSDQ:ATHX) has completed patient enrollment in the single-dose portion of a clinical trial that’s treating blood cancer patients with the company’s stem cell therapy.

Filed Under: Business/Financial News, News Well, Stem Cells Tagged With: Athersys Inc.

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy